PharmaCyte Biotech, Inc. (PMCB) financial statements (2022 and earlier)

Company profile

Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600
LAGUNA HILLS, CA 92653
State of Incorp. NV
Fiscal Year End April 30
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

1/31/2022
TTM
4/30/2021
4/30/2020
4/30/2019
4/30/2018
4/30/2017
4/30/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments86,6402,2028955151,0603,4641,921
Cash and cash equivalents86,6402,2028955151,0603,4641,921
Other undisclosed current assets1747314313822474110
Total current assets:86,8142,2751,0386531,2843,5392,031
Noncurrent Assets
Long-term investments and receivables1,5721,5721,5721,5721,5721,5721,572
Long-term investments1,5721,5721,5721,5721,5721,5721,572
Intangible assets, net (including goodwill)3,5493,5493,5493,5493,5493,5493,549
Intangible assets, net (excluding goodwill)3,5493,5493,5493,5493,5493,5493,549
Other noncurrent assets 777778
Other undisclosed noncurrent assets8      
Total noncurrent assets:5,1295,1295,1295,1295,1295,1295,129
TOTAL ASSETS:91,9437,4046,1675,7826,4138,6677,160
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6137251,002743644580488
Accounts payable93172186122353366336
Accrued liabilities520553817621292215152
Debt  29    
Other undisclosed current liabilities      150
Total current liabilities:6137251,031743644580638
Noncurrent Liabilities
Long-term debt and lease obligation  46    
Long-term debt, excluding current maturities  46    
Total noncurrent liabilities:  46    
Total liabilities:6137251,078743644580638
Stockholders' equity
Stockholders' equity attributable to parent91,3306,6795,0895,0405,7698,0876,523
Common stock201641191019178
Additional paid in capital201,573114,109108,805104,966101,63697,13091,135
Accumulated other comprehensive income (loss)(19)(20)(22)(14)(5)21
Accumulated deficit(110,226)(107,409)(103,858)(100,031)(95,964)(89,135)(84,692)
Total stockholders' equity:91,3306,6795,0895,0405,7698,0876,523
TOTAL LIABILITIES AND EQUITY:91,9437,4046,1675,7826,4138,6677,160

Income statement (P&L) ($ in thousands)

1/31/2022
TTM
4/30/2021
4/30/2020
4/30/2019
4/30/2018
4/30/2017
4/30/2016
Revenues   33153 11
Other income (1)(0)33153 11
Gross profit:   33153 11
Operating expenses(3,919)(3,623)(3,826)(4,101)(6,981)(4,442)(6,073)
Other undisclosed operating income (loss) 10(33)(153) (11)
Operating loss:(3,919)(3,623)(3,826)(4,101)(6,981)(4,442)(6,073)
Nonoperating income (expense)16872(0)33153(2)9
Investment income, nonoperating26      
Other nonoperating income (expense)9772(0)33153(2)9
Interest and debt expense(2)(3)(0)  (2)(1)
Loss before gain (loss) on sale of properties:(3,752)(3,554)(3,827)(4,067)(6,829)(4,445)(6,065)
Other undisclosed net loss(26)      
Net loss:(3,778)(3,554)(3,827)(4,067)(6,829)(4,445)(6,065)
Other undisclosed net income attributable to parent230  21
Net loss available to common stockholders, diluted:(3,776)(3,551)(3,827)(4,067)(6,829)(4,444)(6,064)

Comprehensive Income ($ in thousands)

1/31/2022
TTM
4/30/2021
4/30/2020
4/30/2019
4/30/2018
4/30/2017
4/30/2016
Net loss:(3,778)(3,554)(3,827)(4,067)(6,829)(4,445)(6,065)
Other comprehensive income (loss)21(8)(9)(6)1(1)
Comprehensive loss:(3,776)(3,553)(3,835)(4,076)(6,835)(4,444)(6,066)
Other undisclosed comprehensive income, net of tax, attributable to parent230  21
Comprehensive loss, net of tax, attributable to parent:(3,775)(3,550)(3,835)(4,076)(6,835)(4,443)(6,064)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: